v.szabo
TL3 Analytical chemist · Budapest, HU
Peptide content assay versus purity assay — they are different numbers and the confusion causes half the arguments in the analytics categories.
Joined 25 November 2024 · last posted 4d · groups: analytical-chemists, wiki-editors
147 posts, newest first. Showing up to 150.
-
Immortal time bias in a claims-database study — one year on Replied, post #40 · Evidence › Study critique · 23 Jul 2026 · 2 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Pooling trials with different estimands Replied, post #122 · Evidence › Meta-analyses · 23 Jul 2026 · 24 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #22 · Practice › Side effects · 19 Jul 2026 · 8 likes post #21 is right about the mechanism and I think understates the practical bit. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect…
-
What to bring: records that a clinician can actually use Replied, post #7 · Clinical › Prescriber conversations · 19 Jul 2026 · 7 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #35 · Analytics › HPLC & UHPLC · 14 Jul 2026 · 3 likes post #34 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
A site rotation scheme that is easy enough to actually follow Replied, post #113 · Practice › Administration · 13 Jul 2026 · 22 likes Picking up post #110: that is the part I would want checked first. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate…
-
Aggregate verification data across the directory, with caveats Replied, post #39 · Sourcing › Independent verification · 10 Jul 2026 · 8 likes Coming back to post #37, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Does a peptide degrade silently, with no visual change? Replied, post #67 · Practice › Storage & stability · 10 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The headache that turns out to be dehydration — the long version Replied, post #63 · Nutrition & Training › Hydration & electrolytes · 8 Jul 2026 · 10 likes This follows post #60 rather than contradicting it. Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention…
-
Pages past their review date, listed — does this still hold? Replied, post #41 · Meta › Wiki maintenance · 7 Jul 2026 · 12 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #47 · Analytics › Home & field testing · 2 Jul 2026 · 8 likes Worth separating two things that post #43 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #36 · Analytics › Home & field testing · 28 Jun 2026 · 8 likes Coming back to post #34, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #66 · Compounds › Tirzepatide · 28 Jun 2026 · 2 likes post #65 answers the question as asked. The question underneath it is different. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Sleep quality changes during weight loss Replied, post #4 · Wellbeing › Sleep · 27 Jun 2026 · 20 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #71 · Analytics › HPLC & UHPLC · 25 Jun 2026 · 29 likes Picking up post #68: that is the part I would want checked first. System suitability testing: injections run before and during the sample run to establish whether the…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #16 · Practice › Dosing & titration · 25 Jun 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #57 · Compounds › Tirzepatide · 24 Jun 2026 · 0 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Cold solution and stinging: the simplest fix Replied, post #38 · Practice › Administration · 22 Jun 2026 · 7 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Revisiting: What pooling buys you and what it destroys Replied, post #60 · Evidence › Meta-analyses · 19 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A site rotation scheme that is easy enough to actually follow Replied, post #91 · Practice › Administration · 17 Jun 2026 · 0 likes Worth separating two things that post #87 runs together. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #44 · Start Here › How to Ask · 15 Jun 2026 · 7 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #26 · Practice › Reconstitution · 15 Jun 2026 · 10 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #39 · Start Here › How to Ask · 13 Jun 2026 · 5 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Follow-up: Sleep quality changes during weight loss Replied, post #41 · Wellbeing › Sleep · 9 Jun 2026 · 0 likes This follows post #38 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #39 · Analytics › HPLC & UHPLC · 7 Jun 2026 · 0 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Constipation management, with a dietitian's contribution Replied, post #73 · Practice › Side effects · 1 Jun 2026 · 0 likes Coming back to post #71, because the follow-up matters more than the original answer. Nausea: the most common side effect and the most dose- and titration-dependent…
-
How this community escalates rather than diagnoses — does this still hold? Replied, post #3 · Safety › Adverse events · 27 May 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion with…
-
Blind submission and why it changes minds — the long version Replied, post #100 · Sourcing › Independent verification · 27 May 2026 · 18 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #2 · Pharmacology › Receptor biology · 21 May 2026 · 0 likes This follows the opening post rather than contradicting it. Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite)…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #70 · Sourcing › Vendor reports · 21 May 2026 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Step therapy requirements and how to satisfy them Replied, post #21 · Access › Insurance & coverage · 20 May 2026 · 0 likes This follows post #18 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #62 · Compounds › Tirzepatide · 18 May 2026 · 22 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Pancreatitis history and the risk calculus Replied, post #10 · Safety › Contraindications · 14 May 2026 · 3 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #29 · Clinical › Bloodwork · 6 May 2026 · 0 likes post #28 answers the question as asked. The question underneath it is different. Reference intervals: constructed to contain the central 95% of a reference population,…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #19 · Practice › Administration · 24 Apr 2026 · 6 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Managing an unplanned gap in supply Replied, post #105 · Access › Shortages · 21 Apr 2026 · 30 likes This follows post #102 rather than contradicting it. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they…
-
Request declined, with reasoning — what changed since Replied, post #31 · Meta › Feature requests · 19 Apr 2026 · 0 likes Worth separating two things that post #27 runs together. Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #58 · Outcomes › Body composition · 14 Apr 2026 · 21 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
[2026 update] What a purity-only report leaves out Replied, post #88 · Sourcing › Independent verification · 13 Apr 2026 · 0 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #36 · Compounds › Repair & healing peptides · 12 Apr 2026 · 0 likes This follows post #33 rather than contradicting it. Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are…
-
The most useful thing you learned here that was not the answer you came for Replied, post #33 · Lounge › Off topic · 8 Apr 2026 · 16 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
Spike-and-recover accuracy for a peptide assay Started this topic · Analytics › Method validation · 6 Apr 2026 · 4 likes Posting this under the heading it deserves: Spike-and-recover accuracy for a peptide assay Everything below is what sits behind that. A documentation question rather…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #41 · Practice › Administration · 2 Apr 2026 · 0 likes On post #37 — agreed on the reasoning, with one qualification. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #82 · Practice › Reconstitution · 31 Mar 2026 · 4 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Search filters: what is missing Replied, post #41 · Meta › Site feedback · 29 Mar 2026 · 2 likes Worth separating two things that post #37 runs together. Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what…
-
About the Storage & stability category Replied, post #5 · Practice › Storage & stability · 29 Mar 2026 · 29 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Grapefruit: why this class is not the class that cares Replied, post #85 · Practice › Interactions · 27 Mar 2026 · 9 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #57 · Research Methods › Statistics · 20 Mar 2026 · 8 likes Coming back to post #55, because the follow-up matters more than the original answer. Effect sizes: the magnitude of a difference, not just whether it is statistically…
-
The "under review" status pill and when a moderator applies it Replied, post #25 · Evidence › Preprints · 18 Mar 2026 · 30 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #72 · Pharmacology › Pharmacokinetics · 16 Mar 2026 · 4 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #64 · Research Methods › N-of-1 designs · 14 Mar 2026 · 0 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #28 · Research Methods › N-of-1 designs · 2 Mar 2026 · 13 likes Coming back to post #26, because the follow-up matters more than the original answer. Sample size in n-of-1: you are the sample. Repeated measurements (weekly…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #126 · Access › International · 23 Feb 2026 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #53 · Practice › Interactions · 20 Feb 2026 · 8 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #18 · Practice › Dosing & titration · 15 Feb 2026 · 17 likes Coming back to post #16, because the follow-up matters more than the original answer. When a dose reduction is the correct response to a side effect: if a side effect…
-
Personal import allowances, compared — a second dataset Replied, post #68 · Access › International · 13 Feb 2026 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Research-use-only status: what it means legally and practically Replied, post #3 · Compounds › Other compounds · 9 Feb 2026 · 8 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Trifluoroacetate content and its consequences Replied, post #115 · Analytics › Impurities & related substances · 9 Feb 2026 · 23 likes Worth separating two things that post #111 runs together. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects…
-
Revisiting: Absolute versus relative contraindications Replied, post #20 · Safety › Contraindications · 6 Feb 2026 · 12 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #98 · Sourcing › Independent verification · 28 Jan 2026 · 0 likes I read post #96 twice before replying, because I had assumed the opposite. When results are inconclusive: if a testing service reports "insufficient to verify" on a…
-
Heterogeneity as information rather than as a nuisance Replied, post #73 · Evidence › Meta-analyses · 23 Jan 2026 · 4 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #131 · Documentation › Doc review · 12 Jan 2026 · 12 likes This follows post #128 rather than contradicting it. Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #106 · Analytics › COA interpretation · 8 Jan 2026 · 28 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #25 · Documentation › Wiki requests · 5 Jan 2026 · 0 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #9 · Practice › Storage & stability · 29 Dec 2025 · 18 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #19 · Regional › UK & Ireland · 28 Dec 2025 · 27 likes post #18 is right about the mechanism and I think understates the practical bit. NHS access has been restricted by commissioning criteria, not by licensing. Specialist…
-
Prescription requirements and telehealth models Replied, post #89 · Sourcing › Regulatory · 25 Dec 2025 · 7 likes Coming back to post #87, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #29 · Research Methods › N-of-1 designs · 21 Dec 2025 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Robustness: the parameters worth deliberately varying Replied, post #15 · Analytics › Method validation · 22 Nov 2025 · 15 likes post #14 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Pen dose counters: what a click does and does not guarantee Replied, post #99 · Devices › Pens & autoinjectors · 19 Nov 2025 · 0 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #97 · Compounds › Tirzepatide · 18 Nov 2025 · 9 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
What pooling buys you and what it destroys Replied, post #64 · Evidence › Meta-analyses · 11 Nov 2025 · 6 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
[2026 update] What steady state means for the decision to escalate Replied, post #62 · Practice › Dosing & titration · 11 Nov 2025 · 24 likes This follows post #59 rather than contradicting it. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is…
-
Managing an unplanned gap in supply — what changed since Replied, post #109 · Access › Shortages · 7 Nov 2025 · 0 likes Coming back to post #107, because the follow-up matters more than the original answer. Supply interruptions: official shortage notices are published by regulatory…
-
Batch date after test date, and other internal inconsistencies Replied, post #14 · Analytics › COA interpretation · 4 Nov 2025 · 2 likes Worth separating two things that post #10 runs together. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #9 · Access › Pricing · 2 Nov 2025 · 16 likes Worth separating two things that post #5 runs together. Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower…
-
Second pass at: Why semaglutide's albumin binding is the whole reason weekly dosing works Started this topic · Compounds › Semaglutide · 1 Nov 2025 · 1 like Second pass at: Why semaglutide's albumin binding is the whole reason weekly dosing works Writing it up because I had to work it out twice and would rather nobody else…
-
Lateral-flow and colorimetric approaches: the specificity problem Replied, post #3 · Analytics › Home & field testing · 29 Oct 2025 · 1 like What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #38 · Analytics › Home & field testing · 25 Oct 2025 · 2 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
A 40-week log with the measurement method stated Replied, post #19 · Outcomes › Progress reports · 16 Oct 2025 · 24 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
New subcategory: rationale and scope Replied, post #29 · Meta › Announcements · 15 Oct 2025 · 0 likes post #28 is right about the mechanism and I think understates the practical bit. Archives: older announcements are archived by date. Checking archives is useful if you…
-
Reading SURMOUNT-1 without the press release Replied, post #30 · Compounds › Tirzepatide · 10 Oct 2025 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #138 · Data & Tools › Calculators · 3 Oct 2025 · 0 likes post #137 answers the question as asked. The question underneath it is different. Storage lookup: which conditions (temperature, time) are you considering storing in,…
-
Insurance and replacement policies, compared — the long version Replied, post #21 · Sourcing › Logistics · 30 Sep 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #24 · Practice › Interactions · 29 Sep 2025 · 28 likes On post #20 — agreed on the reasoning, with one qualification. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
-
Follow-up: Why appetite effects are mostly central Replied, post #53 · Pharmacology › Receptor biology · 29 Sep 2025 · 0 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
Revisiting: German, French and Dutch differences, compared Replied, post #77 · Regional › European Union · 24 Sep 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #51 · Compounds › Other compounds · 22 Sep 2025 · 4 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #100 · Data & Tools › Datasets · 10 Sep 2025 · 2 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #32 · Practice › Side effects · 2 Sep 2025 · 18 likes On post #28 — agreed on the reasoning, with one qualification. Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and…
-
When a preprint is the best available evidence and we say so Replied, post #110 · Evidence › Preprints · 28 Aug 2025 · 16 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What this community means by "a source", in practical terms Replied, post #88 · Start Here › Welcome · 27 Aug 2025 · 22 likes Worth separating two things that post #84 runs together. The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you…
-
When a preprint is the best available evidence and we say so Replied, post #67 · Evidence › Preprints · 17 Aug 2025 · 0 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #24 · Evidence › Journal club · 16 Aug 2025 · 13 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
How to read a forest plot, properly, from scratch Replied, post #15 · Evidence › Trials · 13 Aug 2025 · 8 likes Picking up post #12: that is the part I would want checked first. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #75 · Data & Tools › Calculators · 7 Aug 2025 · 5 likes post #74 answers the question as asked. The question underneath it is different. Titration planning: a calculator that shows you the escalation schedule for different…
-
A field-by-field walk through a certificate of analysis Replied, post #141 · Analytics › COA interpretation · 18 Jul 2025 · 0 likes Worth separating two things that post #137 runs together. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and…
-
Sodium, potassium and magnesium when intake drops Replied, post #54 · Nutrition & Training › Hydration & electrolytes · 11 Jul 2025 · 8 likes This follows post #51 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #44 · Data & Tools › Calculators · 6 Jul 2025 · 23 likes Picking up post #41: that is the part I would want checked first. Storage lookup: which conditions (temperature, time) are you considering storing in, and how much…
-
Why the timeline is on the right and not the left Replied, post #35 · Meta › Site feedback · 30 Jun 2025 · 21 likes On post #31 — agreed on the reasoning, with one qualification. Search and findability: if you searched for something and did not find it, report what you searched for…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #37 · Compounds › Semaglutide · 22 Jun 2025 · 7 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Reading a trial's population section before its results — does this still hold? Replied, post #140 · Evidence › Trials · 24 May 2025 · 21 likes post #139 is right about the mechanism and I think understates the practical bit. Open-label design: unblinded trials admit expectation effects. For weight-loss trials…
-
EU-wide position versus national implementation Replied, post #6 · Regional › European Union · 22 May 2025 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #41 · Research Methods › N-of-1 designs · 21 May 2025 · 8 likes I read post #39 twice before replying, because I had assumed the opposite. Blinding: blinding yourself (not knowing which condition you are in) removes expectation…
-
Travel coolers and how long they really hold — the long version Replied, post #3 · Devices › Cold chain · 18 May 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Shipment during summer or to hot climates: consider shipping to a cold-storage facility rather…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #110 · Sourcing › Independent verification · 17 May 2025 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Follow-up: Documentation that appears only after payment Replied, post #58 · Sourcing › Red flags · 8 May 2025 · 0 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #104 · Compounds › Semaglutide · 5 May 2025 · 15 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #10 · Sourcing › Red flags · 3 May 2025 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Metformin co-administration and additive GI effects Replied, post #8 · Practice › Interactions · 22 Apr 2025 · 15 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
UK access routes, dated and sourced — a second dataset Replied, post #60 · Regional › UK & Ireland · 6 Apr 2025 · 1 like Picking up post #57: that is the part I would want checked first. Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #124 · Access › International · 26 Mar 2025 · 0 likes post #123 is right about the mechanism and I think understates the practical bit. Language barriers: if you need to communicate with a supplier, clinician, or regulator…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #118 · Analytics › COA interpretation · 24 Mar 2025 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #10 · Clinical › Bloodwork · 24 Mar 2025 · 12 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Validating a method you did not develop — does this still hold? Replied, post #105 · Analytics › Method validation · 12 Mar 2025 · 5 likes post #104 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Follow-up: What other technical communities get right that we do not Replied, post #35 · Lounge › Off topic · 9 Mar 2025 · 4 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #49 · Compounds › Secretagogues & GH axis · 8 Mar 2025 · 4 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Consistent declarations and why they matter more than clever ones Replied, post #84 · Sourcing › Logistics · 25 Feb 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Consistent declarations and why they matter more than clever ones Replied, post #61 · Sourcing › Logistics · 20 Feb 2025 · 5 likes Coming back to post #59, because the follow-up matters more than the original answer. Packaging integrity on arrival: if a parcel arrives with compromised packaging,…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #52 · Devices › Cold chain · 15 Feb 2025 · 31 likes Coming back to post #50, because the follow-up matters more than the original answer. Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's…
-
Why a pen's dose steps are fixed and what that costs you — one year on Started this topic · Devices › Pens & autoinjectors · 1 Feb 2025 · 15 likes Asking directly, because I could not find a straight answer: Why a pen's dose steps are fixed and what that costs you — one year on I have read the maintained page on…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #24 · Practice › Reconstitution · 22 Jan 2025 · 18 likes This follows post #21 rather than contradicting it. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #149 · Clinical › Prescriber conversations · 17 Jan 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
When to suspect the method rather than the sample Replied, post #64 · Analytics › Method validation · 11 Jan 2025 · 11 likes Worth separating two things that post #60 runs together. Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is…
-
Follow-up: Individual participant data versus aggregate data Replied, post #52 · Evidence › Meta-analyses · 10 Jan 2025 · 22 likes I read post #50 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Identical chromatograms across two different lots Replied, post #73 · Sourcing › Red flags · 7 Jan 2025 · 7 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Body image changing more slowly than the body Replied, post #85 · Wellbeing › Mental health · 20 Dec 2024 · 0 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #154 · Analytics › COA interpretation · 17 Dec 2024 · 4 likes post #153 answers the question as asked. The question underneath it is different. What fields matter on a certificate: lot number matching the vial, test date, the…
-
The topic list is dense — is that deliberate? Replied, post #67 · Meta › Site feedback · 15 Dec 2024 · 29 likes post #66 answers the question as asked. The question underneath it is different. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive,…
-
Fibre intake when total intake falls, and the constipation link Replied, post #7 · Nutrition & Training › Protein & intake · 15 Dec 2024 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] New subcategory: rationale and scope Replied, post #48 · Meta › Announcements · 7 Dec 2024 · 0 likes Picking up post #45: that is the part I would want checked first. Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will…
-
Why "any advice?" is the least effective ending for a post Replied, post #107 · Start Here › How to Ask · 5 Dec 2024 · 23 likes post #106 is right about the mechanism and I think understates the practical bit. The specific question in the title is more useful than you might think. A title like…
-
EMA product information as a primary source — does this still hold? Replied, post #113 · Regional › European Union · 18 Nov 2024 · 27 likes Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
-
EMA product information as a primary source — does this still hold? Replied, post #85 · Regional › European Union · 17 Nov 2024 · 2 likes On post #81 — agreed on the reasoning, with one qualification. Private prescription with self-payment is legal across the EU and is the common route where public…
-
Why "any advice?" is the least effective ending for a post Replied, post #17 · Start Here › How to Ask · 8 Nov 2024 · 8 likes post #16 is right about the mechanism and I think understates the practical bit. Questions you cannot explain: "I cannot say why I am asking this, but is this compound…
-
When to suspect the method rather than the sample Replied, post #33 · Analytics › Method validation · 6 Nov 2024 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #12 · Compounds › Tirzepatide · 27 Oct 2024 · 25 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #15 · Meta › Wiki maintenance · 23 Oct 2024 · 0 likes Scope creep: if a page is attempting too much, suggesting it split into multiple pages can improve clarity.
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #9 · Sourcing › Regulatory · 19 Oct 2024 · 3 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
The topic list is dense — is that deliberate? Replied, post #38 · Meta › Site feedback · 14 Oct 2024 · 22 likes This follows post #35 rather than contradicting it. Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #105 · Clinical › Bloodwork · 13 Oct 2024 · 0 likes This follows post #102 rather than contradicting it. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #44 · Sourcing › Independent verification · 8 Sep 2024 · 17 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Guidelines revision: what changed and why Replied, post #43 · Meta › Announcements · 26 Jul 2024 · 0 likes On post #39 — agreed on the reasoning, with one qualification. Feedback to announcements: if you have feedback on an announced change (not a question, but your…
-
Guidelines revision: what changed and why Replied, post #32 · Meta › Announcements · 25 Jul 2024 · 0 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #51 · Practice › Dosing & titration · 8 Jul 2024 · 2 likes I read post #49 twice before replying, because I had assumed the opposite. Reaching a dose and staying there for a year: the question of whether a stable dose remains…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #7 · Evidence › Journal club · 7 Jul 2024 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Where the four-week escalation interval comes from, and what it is not Replied, post #35 · Practice › Dosing & titration · 30 Jun 2024 · 15 likes I read post #33 twice before replying, because I had assumed the opposite. The four-week escalation interval is a convention from the pivotal trials, not a…